The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer

European Journal of Cancer

Volumn 33, Issue 10, 1997, Pages 1572-1577

  Esteller, M ^a   Garcia A ^a   Martinez Palones J M ^a   Xercavins, J ^a   Reventos J ^a  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

Atypical hyperplasia; Endometrial carcinoma; Gene amplification; K ras; Point mutation; Polymerase chain reaction

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER STAGING; ENDOMETRIUM CANCER; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; ELECTROPHORESIS, AGAR GEL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, RAS; HUMANS; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS;

EID: 0031418171     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00154-8     Document Type: Article

References (33)

1. De Vita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology, 3rd edn. J. B. Lippincot, Philadelphia, PA, 1990.
2. Parazzini F, La Vecchia C, Bocciolone L, Franceshi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991, 41, 1-16.
3. Silverberg E, Lubera J. Cancer statistics, 1988. CA-Cancer J Clin 1988, 38, 5.
4. Gurpide E. Endometrial cancer: biochemical and clinical correlates. J Natl Cancer Inst 1991, 20, 405-416.
5. Kohler MF, Nishii H, Humphrey PA, et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992, 52, 1622-1627.
6. Berchuck A, Rodriguez G, Kinney RB, et al. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 1991, 164, 15-21.
7. Esteller M, Garcia A, Martinez-Palones JM, Cabero A, Reventos J. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction. Cancer 1995, 75, 2139-2146.
8. Scambia G, Benedetti PP, Ferrandina G, et al. Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer 1994, 56, 26-30.
9. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989, 49, 4682-4689.
10. Bos JL. The ras gene family and human carcinogenesis. Mutat Res 1988, 195, 225-271.
11. Winter E, Yamamoto F, Almoguera C, Perucho M. A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells. Proc Nad Acad Sci USA 1985, 85, 7575-7579.
12. Slebos RJC, Habets GGM, Evers SG, Mooi WJ, Rodenhuis S. Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas. Int J Cancer 1991, 48, 51-56.
13. Scambia G, Benedetti PP, Ferrandina G, et al. Expression of ras p21 oncoprotein in normal and neoplastic human endometrium. Gynecol Oncol 1993, 50, 339-346.
14. Boyd JA, Risinger JI. Analysis of oncogene alterations in human endometrial carcinomas: prevalence of ras mutations. Mol Carcinog 1991, 4, 189-195.
15. Mizuuchi H, Nasrim S, Kudo R, Silverberg SG, Greenhouse S, Garrett CT. Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res 1992, 52, 2777-2781.
16. Ignar-Trowbrige D, Risinger JI, Dent GA, et al. Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 1992, 167, 227-232.
17. Fujimoto I, Shimizu Y, Hirai Y, et al. Studies on ras oncogene activation in endometrial carcinoma. Gynecol Oncol 1993, 48, 196-202.
18. Enomoto T, Fujita M, Inoue M, et al. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res 1993, 53, 1883-1888.
19. Sasaki H, Nishii H, Takahashi H, et al. Mutation of the ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 1993, 53, 1906-1910.
20. Caduff RF, Johnston CM, Frank TW. Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Am J Pathol 1995, 146, 182-188.
21. Jiang W, Kahn SM, Guillem JG, Lu SH, Weinstein IB. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal and gastric cancer. Oncogene 1989, 4, 923-928.
22. Frye RA, Benz CC, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989, 4, 1153-1157.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual, 2nd edn. Plain View, Cold Spring Harbor Laboratory Press, New York, 1989.
24. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. High rate of MDR-1 and heterogeneous pattern of MRP expression without gene amplification in endometrial cancer. Int J Cancer 1995, 63, 798-803.
25. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 1990, 50, 6139-6145.
26. Enomoto T, Inoue M, Perantoni AO, et al. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 1991, 51, 5308-5314.
27. Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res 1994, 54, 1604-1607.
28. Boyd J. Molecular biology in the clinicopathologic assessment of endometrial carcinoma subtypes. Gynecol Oncol 1996, 61, 163-165.
29. Mutter GL, Chaponot ML, Fletcher JA. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 1995, 146, 501-508.
30. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart. Lab Invest 1997, 76, 1-8.
31. Imamura T, Arima T, Kato H, Miyamoto S, Sasazuki T, Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas, Int J Cancer 1992, 51, 47-52.
32. Abeler VM, Vergote IB, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996, 78, 1740-1747.
33. Khol NE, Omer CA, Conner MW, et al. Inhibition of farnesyl-transferase induces regression of mammary and salivary carcinomas in rat transgenic mice. Nat Med 1995, 1, 792-797.